Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 429-900-5 | CAS number: 82356-51-2
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- From 2000-03-14 to 2000-04-07
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- Study performed according to OECD test guideline No. 406 and in compliance with GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 000
- Report date:
- 2000
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- 17 July 1992
- Deviations:
- no
- Principles of method if other than guideline:
- not applicable
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- At the time of study performance, the LLNA method was not adopted.
Test material
- Reference substance name:
- (5E)-3-Methyl-5-cyclopentadecen-1-one
- Cas Number:
- 101151-17-1
- Molecular formula:
- C16 H28 O
- IUPAC Name:
- (5E)-3-Methyl-5-cyclopentadecen-1-one
- Reference substance name:
- (5Z)-3-Methyl-5-cyclopentadecen-1-one
- Cas Number:
- 21944-94-5
- Molecular formula:
- C16 H28 O
- IUPAC Name:
- (5Z)-3-Methyl-5-cyclopentadecen-1-one
- Reference substance name:
- (4E)-3-Methyl-4-cyclopentadecen-1-one
- Cas Number:
- 62221-84-5
- Molecular formula:
- C16 H28 O
- IUPAC Name:
- (4E)-3-Methyl-4-cyclopentadecen-1-one
- Test material form:
- liquid
- Details on test material:
- - Physical state: Liquid
- Storage conditions: stored at ambient room temperature
Constituent 1
Constituent 2
Constituent 3
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Davidson's Mill Farms, South Brunswick, NJ
- Age at study initiation: young adults
- Weight at study initiation: M: 390-505 g; F: 381-486 g
- Housing: group housed in suspended stainless steel caging with mesh floors
- Diet (e.g. ad libitum): Pelleted Purina Guinea Pig Chow #5025 ad libitum
- Water (e.g. ad libitum): Filtered tap water ad libitum
- Acclimation period: 18 days
- Indication of any skin lesions: No skin lesion identified
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-22 °C
- Humidity (%): 36-70 %
- Air changes (per hr): no data
- Photoperiod: 12 hrs dark / 12 hrs light
IN-LIFE DATES: From: 2000-25-02 To: 2000-04-07
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- other: mineral oil
- Concentration / amount:
- 40% w/v
- Day(s)/duration:
- Day 0
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
- Route:
- epicutaneous, semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- 100 %
- Day(s)/duration:
- Day 7 / 48 hours
- Adequacy of induction:
- non-irritant substance, but skin pre-treated with 10% SDS
Challenge
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- 100 %
- Day(s)/duration:
- Day 21 / 24 hours
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- 17 preliminary test animals, 20 test animals, 10 control animals
- Details on study design:
- RANGE FINDING TESTS:
- Intradermal injections: 50%, 40%, 30%, 20%, 10%, 5%, 4%, 3%, 2%, 1%, 0.5% and 0.1% w/w in 70/30 DEP/ETOH. 6 test sites/guinea-pig, 4 guinea-pigs. Due to severe irritation noted for all sites, 2 additional animals were injected with just the vehicle and exhibited the same severe response. One animal was used to evaluate the possible alternatives with propylene and mineral oil. Mineral oil was chosen for the intradermal injections to yield concentrations of 50%, 40%, 30%, 20%, 10% and 5%. The concentration which produced mild to moderate irritation was 40%.
- Topical induction: 100%, 75%, 50%, 25% w/w in 70/30 DEP/ETOH. 4 test sites/guinea-pig, 4 guinea-pigs. The concentration which produced mild to moderate irritation was 100%.
- Topical challenge: 100%, 75%, 50%, 25% w/w in 70/30 DEP/ETOH. 4 test sites/guinea-pig, 4 guinea-pigs. The highest concentration that produced responses in 4 guinea-pigs no more severe than 2 scores of 0.5 and 2 scores of 0 was 100%.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2, intradermal injections and topical application
- Exposure period: 48h for topical application
- Test groups:
INTRADERMAL: 3 pairs of intradermal injection (0.1 mL) in the shaved anterior shoulder on Day 0 after shaving as follows:
- 1/ 50% FCA
- 2/ test substance 40% in mineral oil
- 3/ test substance 40% in 50% FCA
SODIUM LAUREL SULFATE: As the substance is not a skin irritant, 24 hours prior to the topical application, the shoulder area was pre-treated with 5 %SLS mixture in petrolatum. Prior to the topical induction, the test sites were gently wiped with ethanol then water.
TOPICAL: 7 days after intradermal injections, 0.8 mL of the test substance (100%) was applied and covered with a gauze patch secured in place and wrapped with non-allergenic Durapore adhesive tape (semi-occlusive tape). After the 48 hour exposure period, the patches were removed and the test sites were wiped gently with DEP/ETOH then water, using a clean towel to remove any residual substance.
- Control group: similarly treated with the exception that the test substance was omitted.
- Evaluation (hr after challenge): approximately 24 and 48 hours after patch removal.
B. CHALLENGE EXPOSURE
- No. of exposures:
- Day(s) of challenge: 21 days after test initiation
- Exposure period: 24 hours
- Test groups: 0.4 mL of the test substance was applied using an occlusive 25 mm Hilltop Chamber®. The chambers were secured in place and wrapped with non-allergenic Durapore adhesive tape. After the 24 hours exposure period, the chambers were removed and the sites were gently wiped with DEP/ETOH then water, using a clean towel to remove any residual substance.
- Control group: similarly treated with the exception that the test substance was omitted
- Site: right side
- Concentrations: 100%
- Evaluation (hr after challenge): approximately 24 and 48 hours after patch removal. - Challenge controls:
- None
- Positive control substance(s):
- yes
- Remarks:
- HCA (at least 85-91.7% pure), as an historical positive control
Results and discussion
- Positive control results:
- INDUCTION PHASE: Severe erythema (3) was noted at all positive control sites during the topical induction phase.
CHALLENGE PHASE: All ten positive control animals exhibited signs of a sensitisation response (faint to severe erythema[1-3]) 24 hours after challenge. Similar indications persisted in 4 animals through 48 hours
In vivo (non-LLNA)
Resultsopen allclose all
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- Very faint erythema (0.5) was noted in 8/20 animals
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- Irritation (grade 0.5) persisted in 5/20 animals
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 25 %
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- faint to severe erythema[1-3]
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 25 %
- No. with + reactions:
- 4
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- very faint erythema (0.5) was noted in 5/10 animals
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- Irritation (grade 0.5) persisted in 4/10 animals
- Remarks on result:
- no indication of skin sensitisation
Any other information on results incl. tables
Topical induction phases:
- Test animals (100% test substance): very faint to faint erythema (0.5 -1) in 9/20 animals 24 hours after removal of patch. Very faint erythema (0.5) persisted in 6/20 through 48 hours.
- Negative controls: very faint to faint erythema (0.5 -1) in 6/10 animals 24 hours after removal of patch. Very faint erythema (0.5) persisted in 4/10 through 48 hours.
- Positive control (100% HCA): Severe erythema (3) was noted at all positive control sites
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the test conditions, ST 19 C 99 is not classified according to the Regulation EC No. 1272/2008 (CLP) and to the GHS.
- Executive summary:
In a dermal sensitisation study performed according to the EU test method B.6 and in compliance with GLP, ST 19 C 99 was tested in female Hartley guinea-pigs using the Guinea-Pig Maximisation Test method (20 treated animals + 10 controls).
The preliminary study determined the concentration which produced mild to moderate irritation to be used for the intradermal induction (40%) and for the topical induction (100%). 100% was selected as the highest non-irritant test substance concentration for the challenge.
ST 19 C 99 diluted in mineral oil at 40% (w/w) was administered by injection for intradermal induction. As the substance was not a skin irritant, 24 hours prior to the topical application, the site was pre-treated with 5% w/w sodium laurel sulphate in petrolatum. Topical induction was performed with ST 19 C 99 as supplied, 7 days after intradermal injections. For the challenge, ST 19 C 99 was tested at 100%.
The sensitivity of the guinea-pig is checked periodically at Product Safety Labs with HCA, a known sensitizer.
ST 19 C 99 did not produce evidence of skin sensitization during the study.
Under the test conditions, ST 19 C 99 is not classified according to the Regulation EC No. 1272/2008 (CLP) and to the GHS.
This study is considered as acceptable and satisfies the requirement for sensitisation endpoint.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
